Skip to main content
Buy WaitModerate Confidence
Investment thesis

A high-quality insurance brokerage franchise with excellent cash conversion and an unbroken four-quarter earnings beat streak is navigating a confirmed near-term price downtrend with heavy revenue concentration in a single business segment—warranting a patient, watch-and-wait stance while the technical setup stabilizes.

Thesis pillars

  • Revenue Concentrated In Single Segment↓Deteriorating
  • Quality Franchise Exceptional Cash Conversion→Stable
  • Confirmed Near Term Price Downtrend→Stable
  • +1 more pillar — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Marsh (MRSH) Stock Analysis

Buy WaitVALUE-TRAP 1/5Moderate Confidence

Financial Services · Insurance Brokers

Earnings in 0 days (2026-10-15). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Wait for pullback to $168.78. At $178.40 the A.R:R is 0.3:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $168.78 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%).

Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) —... Read more

$178.40+2.2% A.UpsideScore 5.5/10#11 of 15 Insurance Brokers
QualityF-score7 / 9FCF yield5.62%
IncomeYield2.24%(5y avg 1.45%)Payout44.01%sustainable
Entry $168.78(Default 5pct Sticky)Stop $162.26Target $182.40(analyst − 10%)A.R:R 0.3:1
Analyst target$202.67+13.6%21 analysts
$182.40our TP
$178.40price
$202.67mean
$238

Wait for pullback to $168.78. At $178.40 the A.R:R is 0.3:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $168.78 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 0 days. Wait until post-earnings. Score 5.5/10, moderate confidence.

Passes 4/7 gates (positive momentum, clean insider activity, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: moderate.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-15
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 15, 2026today· next earnings call

Thesis

Rewards
Sector modifier (Financial Services): +1.0
Risks
Concentration risk — Product: Risk and Insurance Services (64.0%)
Concentration risk — Product: Marsh Risk (54.0%)
Analyst target reached - limited upside remaining

Key Metrics

P/E (TTM)21.8
P/E (Fwd)15.6
Mkt Cap$85.1B
EV/EBITDA13.7
Profit Mgn14.2%
ROE25.9%
Rev Growth6.2%
Beta0.58
Dividend2.24%
Rating analysts31

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C1.14bearish
IV70%elevated
Max Pain$250+40.1% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductRisk and Insurance Services64%
    10-K Item 1: 'RISK AND INSURANCE SERVICES ... accounted for approximately 64% of the Company's total revenue in 2025'
  • HIGHProductMarsh Risk54%
    10-K Item 1: 'MARSH RISK ... generated approximately 54% of the Company's total revenue in 2025'

Material Events(8-K, last 90d)

  • 2026-06-04Item 1.01MEDIUM
    Marsh entered a new Amended and Restated 5-year $4.25 billion multi-currency unsecured revolving credit facility with Citibank, N.A. as administrative agent, maturing June 2031. Interest at Term SOFR plus a fixed margin varying with Marsh's credit ratings.
    SEC filing →
  • 2026-06-04Item 1.02MEDIUM
    Prior revolving credit facility terminated in connection with entry into Amended and Restated 5-year $4.25 billion credit agreement with Citibank, N.A. dated June 2, 2026. No reason cited beyond routine refinancing and extension.
    SEC filing →
  • 2026-04-14Item 5.02LOW
    Mark McGivney appointed EVP, Chief Operating Officer & CFO effective April 15, 2026, expanding his role from SVP and CFO (held since January 2016). Annual base salary set at $1,250,000. McGivney retains CFO title; no separate CFO successor named.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.2
Support Resistance
0.8
52w Position
7.5

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
3.5
Revenue Growth
4.0
GatesA.R:R 0.3 < 1.5@spotEARNINGS PROXIMITY 0d<=7dExecutive change: officer departure/appointmentMomentum 6.5>=5.5Insider activity: OKSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Moderate
RSI
75 · Overbought
↑ 20D MA↓ 50D MA↑ 200D MAGOLDEN CROSSSupport $166.27Resistance $179.40

Price Targets

$162
$169
$182
A.Upside+2.2%
A.R:R0.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeRisk-Off

Risk Alerts

! Target reached (2.2% upside)
! Earnings in 0 days - binary event risk
! asymmetry at 0.3 (below the engine's 1.5 threshold)@spot

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-10-15 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MRSH stock a buy right now?

Wait for pullback to $168.78. At $178.40 the A.R:R is 0.3:1 — below the 1.5:1 minimum for BUY_NOW. Engine's entry $168.78 (Default 5pct Sticky) is the shallowest technical level that clears the 2:1 A.R:R minimum. Key risks: Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%). Chart setup: No clear chart pattern; technical signals are mixed. Earnings in 0 days. Wait until post-earnings. Target $182.40 (+2.2%), stop $162.26 (−9.9%), A.R:R 0.3:1. Score 5.5/10, moderate confidence.

What is the MRSH stock price target?

Take-profit target: $182.40 (+2.2% upside). Target $182.40 (+2.2%), stop $162.26 (−9.9%), A.R:R 0.3:1. Stop-loss: $162.26.

What are the risks of investing in MRSH?

Concentration risk — Product: Risk and Insurance Services (64.0%); Concentration risk — Product: Marsh Risk (54.0%); Analyst target reached - limited upside remaining.

Is MRSH overvalued or undervalued?

Marsh trades at a P/E of 21.8 (forward 15.6). TrendMatrix value score: 5.9/10. Verdict: Buy (Wait for Entry).

What do analysts say about MRSH?

31 analysts cover MRSH with a consensus score of 3.5/5. Average price target: $203.

What does Marsh do?Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance...

Marsh & McLennan Companies generated $27 billion in annual revenue in 2025 through two segments — Risk and Insurance Services (approximately 64% of revenue, via Marsh Risk and Guy Carpenter) and Consulting (approximately 36%, via Mercer and Marsh Management Consulting) — advising clients in 130 countries with over 95,000 employees. Revenue comes from insurance and reinsurance broking commissions, client fees for consulting and investment management, and fiduciary interest income on premiums held for clients.

Related stocks: WTW (Willis Towers Watson Public Lim) · BRO (Brown & Brown, Inc.) · RYAN (Ryan Specialty Holdings, Inc.) · AON (Aon plc) · ERIE (Erie Indemnity Company)
Home › Stocks › MRSH

Latest news

Latest News

Yahoo Finance15d agoEarnings
MarketBeat15d agoAnalyst
Yahoo Finance78d ago
TradingView92d ago
Yahoo Finance17h ago
TradingView1d agoEarnings
MarketBeat8d agoAnalyst
StockStory8d ago
Simply Wall Street16d agoProduct
Yahoo Finance16d ago
MarketBeat16d ago
Es.tradingview.com23d ago
TradingView23d ago
Moomoo86d ago
StockStory86d ago
TradingView86d ago
FinancialContent86d ago
Quiver Quantitative86d agoEarnings
Yahoo Finance93d ago
Yahoo Finance93d agoEarnings
Loading more...